Defeng Xu
Impact in
- Toxicology top 2%
- Bioactive Compounds and Antitumor Agents
- Molecular Medicine top 5%
- Curcumin's Biomedical Applications
Papers in
-
- Synthesis and Biological Evaluation 12
- Synthesis and Catalytic Reactions 6
- Co-authors
- Chawnshang Chang (11 shared papers)Hang Hu (35 shared papers)Shuyuan Yeh (8 shared papers)Shaoshun Li (10 shared papers)Liang Liang (2 shared papers)Hiroshi Miyamoto (2 shared papers)Tzu‐Hua Lin (3 shared papers)Lei Li (2 shared papers)
- Journals
- Journal of Drug Delivery Science and Technology (4 papers)Chinese Chemical Letters (4 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Journal of Electroanalytical Chemistry (2 papers)Cancer Letters (2 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Defeng Xu
101 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 104
- Toxicology 108
- Molecular Medicine 108
- Complementary and alternative medicine 129
- Biomaterials 166
- Cancer Research 185
Countries citing papers authored by Defeng Xu
This map shows the geographic impact of Defeng Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Defeng Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Defeng Xu more than expected).
Fields of papers citing papers by Defeng Xu
This network shows the impact of papers produced by Defeng Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Defeng Xu. The network helps show where Defeng Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Defeng Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 108 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 120 | |
| 2 | 2013 | 102 | |
| 3 | 2013 | 99 | |
| 4 | 2014 | 76 | |
| 5 | 2012 | 71 | |
| 6 | 2011 | 64 | |
| 7 | 2012 | 61 | |
| 8 | 2012 | 59 | |
| 9 | 2014 | 50 | |
| 10 | 2016 | 47 | |
| 11 | 2021 | 46 | |
| 12 | 2021 | 43 | |
| 13 | 2017 | 38 | |
| 14 | 2012 | 38 | |
| 15 | 2021 | 34 | |
| 16 | 2022 | 29 | |
| 17 | 2019 | 29 | |
| 18 | 2014 | 25 | |
| 19 | 2011 | 24 | |
| 20 | 2020 | 24 |
About Defeng Xu
Defeng Xu is a scholar working on Organic Chemistry, Molecular Biology, Pulmonary and Respiratory Medicine, Biomaterials and Biomedical Engineering, having authored 108 papers that have together received 1.6k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (14 papers), Prostate Cancer Treatment and Research (12 papers), Synthesis and Biological Evaluation (12 papers), Nanoplatforms for cancer theranostics (11 papers), Bioactive Compounds and Antitumor Agents (9 papers), Curcumin's Biomedical Applications (9 papers), Photodynamic Therapy Research Studies (6 papers) and Synthesis and Catalytic Reactions (6 papers). The work is most often cited by research in Toxicology (108 citations), Molecular Medicine (108 citations), Complementary and alternative medicine (129 citations), Biomaterials (166 citations) and Cancer Research (185 citations). Defeng Xu has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Chawnshang Chang, Hang Hu, Shuyuan Yeh, Shaoshun Li, Liang Liang, Hiroshi Miyamoto, Tzu‐Hua Lin, Lei Li, Huan Zhou and Wen Zhou. Their work appears in journals such as Journal of Drug Delivery Science and Technology, Chinese Chemical Letters, Bioorganic & Medicinal Chemistry Letters, Journal of Electroanalytical Chemistry and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.